Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21160747 | 0.86 | TSHR (0.40) | TDP1ALDH1A1LMNATP53MAPT | |
| SCHEMBL22048805 | 0.85 | HTT (0.57) | TDP1NPC1ALDH1A1LMNATP53 | |
| SCHEMBL20999268 | 0.81 | — | — | |
| SCHEMBL103783 | 0.63 | ALDH1A1 (0.58) | TDP1ALDH1A1TP53TSHRTGM2 | |
| SCHEMBL22840022 | 0.63 | TSHR (0.40) | TDP1ALDH1A1TP53TSHRHTT | |
| SCHEMBL10860893 | 0.62 | ALDH1A1 (0.73) | TDP1NPC1ALDH1A1LMNATP53 | |
| SCHEMBL19276537 | 0.61 | ALDH1A1 (0.55) | TDP1ALDH1A1TP53MAPTTSHR | |
| SCHEMBL22694011 | 0.60 | ENPP2 (0.38) | ENPP2 | |
| SCHEMBL2889896 | 0.60 | TLR9 (0.67) | TDP1NPC1ALDH1A1LMNATP53 | |
| SCHEMBL19828533 | 0.59 | ALDH1A1 (0.32) | ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200332045-A1 | CAPPED DUAL-HEADED ORGANOALUMINUM COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2020-10-22 | — | — | US | disclosed |
| EP-3190144-B1 | EPOXY-MODIFIED SILICONE RESIN, MAKING METHOD, CURABLE COMPOSITION, AND ELECTRONIC PART | SHINETSU CHEMICAL CO (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-9896550-B2 | Epoxy-modified silicone resin, making method, curable composition, and electronic part | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-02-20 | — | — | US | disclosed |
| US-20170198102-A1 | EPOXY-MODIFIED SILICONE RESIN, MAKING METHOD, CURABLE COMPOSITION, AND ELECTRONIC PART | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| US-9695287-B2 | Curable organo polysiloxane composition, encapsulant, and electronic device | SAMSUNG SDI CO., LTD. (KR) | 2017-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200332045-A1 | CAPPED DUAL-HEADED ORGANOALUMINUM COMPOSITIONS | CAPG, C5, CDS2 | TDP1 3529/4885NPC1 1837/4885ALDH1A1 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.